Menu Search
Equities

Besunyen Holdings Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
926:HKG.HS

Besunyen Holdings Co Ltd

Actions
  • Price (HKD)2.52
  • Today's Change0.00 / 0.00%
  • Shares traded4.00k
  • 1 Year change+7.69%
  • Beta0.2402
Data delayed at least 15 minutes, as of Feb 06 2026 07:13 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Besunyen Holdings Co Ltd is a company primarily engaged in manufacturing and sales of therapeutic tea products. The Company operates its business through two segments. The Tea Products segment is engaged in the manufacturing and sales of tea products including Detox tea, Slimming tea, Fit tea, Relief tea and others. The Weight-Loss and Other Medicines segment is engaged in the sales of weight-loss and other medicines, such as Orlistat weight-loss medicines, nutrition meal replacements, probiotics and enzymes. The Company sells its products under the brand Besunyen. The Company’s product therapeutic functions cover weight loss, laxative relief, physical fatigue relief, sleep improvement, reduction of skin age spots, immunity enhancement, assistance in lowering blood sugar level and others. The Company mainly conducts its business in the domestic market.

  • Revenue in HKD (TTM)550.26m
  • Net income in HKD21.83m
  • Incorporated2009
  • Employees129.00
  • Location
    Besunyen Holdings Co LtdRoom 1303, 13/FChina Resources Building, 26 Harbour RoaBEIJING 102433ChinaCHN
  • Phone+86 1 069398655
  • Fax+852 23248200
  • Websitehttp://www.besunyen.com
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.